ARCA biopharma, Inc.

The current price of ABIO is 3.25 USD — it has increased by 1.25% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ARCA biopharma, Inc. stocks are traded under the ticker ABIO.

ARCA biopharma, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

ABIO stock is 6.07% volatile and has beta coefficient of −0.49. Check out the list of the most volatile stocks — is ARCA biopharma, Inc. there?

ABIO earnings for the last quarter are −0.33 USD whereas the estimation was −1.87 USD which accounts for 82.35% surprise. Estimated earnings for the next quarter are −2.37 USD. See more details about ARCA biopharma, Inc. earnings.

Yes, you can track ARCA biopharma, Inc. financials in yearly and quarterly reports right on TradingView.

ABIO net income for the last quarter is ‪−1.09 M‬ USD, while the quarter before that showed ‪−1.42 M‬ USD of net income which accounts for 23.53% change. Track more ARCA biopharma, Inc. financial stats to get the full picture.

Today ARCA biopharma, Inc. has the market capitalization of ‪46.55 M‬, it has increased by 75.44% over the last week.

No, ABIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ABIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCA biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ABIO reached its all-time high on Feb 18, 2000 with the price of 6320761.03 USD, and its all-time low was 1.56 USD and was reached on Jan 19, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 5.00 employees. See our rating of the largest employees — is ARCA biopharma, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCA biopharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCA biopharma, Inc. stock shows the buy signal. See more of ARCA biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.